This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Using closed-loop in type 1 pregnancy associated with type 1 diabetes

pregnancy
Credit: CC0 Public Domain

A new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The study is published in Diabetes Technology & Therapeutics (DTT).

Julia Lawton, from the University of Edinburgh, and co-authors, on behalf of the AiDAPT Collaborative Group, interviewed closed-loop participants in the Automated insulin Delivery Amongst Pregnant women with T1D (AiDAPT) trial.

"Women described how closed-loop lessened the physical and mental demands of management, enabling them to feel more normal and sleep better," reported the investigators. "By virtue of spending increased time-in-range, women also worried less about risks to their baby and being judged negatively by ."

"To realize fully the benefits of closed-loop, would benefit from initial, intensive oversight and support together with closed-loop specific education and training," stated the investigators.

"No closed-loop system is approved in the U.S. for pregnancy use as the targets needed are much tighter during pregnancy associated with T1D," states Satish Garg, MD, Editor-in-Chief of Diabetes Technology & Therapeutics, and Professor, University of Colorado Denver, Barbara Davis Center for Diabetes.

"The only system that allows that is CamAPS FX, which is approved in Europe and Australia. The percentage of time that participants spent in the pregnancy-specific target glucose range (63 to 140 mg/dL) as measured by from 16 weeks' gestation until delivery was significantly higher among participants in the closed-loop group than among those in the standard-care group, with a difference between groups of 10.5 percentage points. I recently wrote an editorial in the New England Journal of Medicine on this topic: 'Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.'"

More information: Julia Lawton et al, Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy, Diabetes Technology & Therapeutics (2023). DOI: 10.1089/dia.2023.0323

Journal information: New England Journal of Medicine
Citation: Using closed-loop in type 1 pregnancy associated with type 1 diabetes (2023, October 12) retrieved 24 February 2024 from https://medicalxpress.com/news/2023-10-closed-loop-pregnancy-diabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Hybrid closed-loop technology improves maternal glucose levels for pregnant women with type 1 diabetes: Clinical trial

1 shares

Feedback to editors